P48426 (PI42A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha EC=2.7.1.149 Alternative name(s): 1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha Diphosphoinositide kinase 2-alpha PIP5KIII Phosphatidylinositol 5-phosphate 4-kinase type II alpha Short name=PI(5)P 4-kinase type II alpha Short name=PIP4KII-alpha PtdIns(4)P-5-kinase B isoform PtdIns(4)P-5-kinase C isoform PtdIns(5)P-4-kinase isoform 2-alpha | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 406 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Catalyzes the phosphorylation of phosphatidylinositol 5-phosphate (PtdIns5P) on the fourth hydroxyl of the myo-inositol ring, to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May exert its function by regulating the levels of PtdIns5P, which functions in the cytosol by increasing AKT activity and in the nucleus signals through ING2. May regulate the pool of cytosolic PtdIns5P in response to the activation of tyrosine phosphorylation. May negatively regulate insulin-stimulated glucose uptake by lowering the levels of PtdIns5P. May be involved in thrombopoiesis, and the terminal maturation of megakaryocytes and regulation of their size. Ref.9 |
| Catalytic activity | ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. Ref.8 |
| Subunit structure | Homodimer By similarity. Interacts with PIP4K2B. Interaction with PIP4K2B may regulate localization to the nucleus. Ref.13 |
| Subcellular location | Cell membrane By similarity. Nucleus. Cytoplasm. Note: May translocate from the cytosol to the cell membrane upon activation of tyrosine phosphorylation. May translocate from the inner to the outer segments of the rod photoreceptor cells in response to light By similarity. Localization to the nucleus is modulated by the interaction with PIP4K2B. Ref.13 |
| Tissue specificity | Expressed ubiquitously, with high levels in the brain. Present in most tissues, except notably skeletal muscle and small intestine. Ref.1 Ref.3 |
| Sequence similarities | Contains 1 PIPK domain. |
| Caution | This protein was previously thought to be a phosphatidylinositol 4-phosphate 5-kinase. |
| Biophysicochemical properties | Kinetic parameters: KM=50 µM for phosphatidylinositol-5- phosphate Ref.13 Vmax=466 pmol/min/µg enzyme |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 406 | 405 | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | PRO_0000185465 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 33 – 405 | 373 | PIPK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.11 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 3 | 1 | Phosphothreonine Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 14 | 1 | Phosphoserine Ref.10 Ref.11 Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 89 | 1 | N6-acetyllysine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 145 | 1 | N6-acetyllysine Ref.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 7 | 1 | L → I. Corresponds to variant rs11813789 [ dbSNP | Ensembl ]. | VAR_059764 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 251 | 1 | N → S. Ref.3 Corresponds to variant rs10828317 [ dbSNP | Ensembl ]. | VAR_024565 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 131 | 1 | G → L: Abolishes catalytic activity; when associated with F-138. Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 138 | 1 | Y → F: Abolishes catalytic activity; when associated with L-131. Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 101 – 103 | 3 | LRE → CGK in AAB35041. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 109 | 1 | D → V in AAB35041. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 143 | 1 | I → M in AAB35041. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 177 – 178 | 2 | QF → HL in AAB35041. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 333 | 1 | D → E in AAB35041. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 36 – 52 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 63 – 67 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 69 – 80 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 81 – 83 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 86 – 94 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 95 – 104 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 109 – 117 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 134 – 136 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 140 – 147 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 149 – 168 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 169 – 171 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 178 – 186 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 189 – 197 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 202 – 204 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 207 – 212 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 215 – 217 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 223 – 226 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 228 – 230 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 235 – 240 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 249 – 268 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 271 – 273 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 275 – 282 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 283 – 291 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 334 – 336 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 340 – 342 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 351 – 358 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 362 – 364 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 390 – 404 | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The sequence of phosphatidylinositol-4-phosphate 5-kinase defines a novel family of lipid kinases." Boronenkov I.V., Anderson R.A. J. Biol. Chem. 270:2881-2884(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 30-42; 74-88; 93-112; 141-145; 254-259; 281-297 AND 383-406, TISSUE SPECIFICITY. Tissue: Placenta. |
| [2] | Boronenkov I.V. Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO 298-310 AND 381-382. |
| [3] | "The cloning and sequence of the C isoform of PtdIns4P 5-kinase." Divecha N., Truong O., Hsuan J.J., Hinchliffe K.A., Irvine R.F. Biochem. J. 309:715-719(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, VARIANT SER-251. Tissue: Leukocyte. |
| [4] | NHLBI resequencing and genotyping service (RS&G) Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Hippocampus. |
| [8] | "A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate." Rameh L.E., Tolias K.F., Duckworth B.C., Cantley L.C. Nature 390:192-196(1997) [PubMed] [Europe PMC] [Abstract] Cited for: CATALYTIC ACTIVITY. |
| [9] | "Regulation of extranuclear PtdIns5P production by phosphatidylinositol phosphate 4-kinase 2alpha." Wilcox A., Hinchliffe K.A. FEBS Lett. 582:1391-1394(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3 AND SER-14, MASS SPECTROMETRY, CLEAVAGE OF INITIATOR METHIONINE. |
| [12] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-89 AND LYS-145, MASS SPECTROMETRY. |
| [13] | "PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha." Bultsma Y., Keune W.-J., Divecha N. Biochem. J. 430:223-235(2010) [PubMed] [Europe PMC] [Abstract] Cited for: BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION WITH PIP4K2B, SUBCELLULAR LOCATION, MUTAGENESIS OF GLY-131 AND TYR-138, IDENTIFICATION BY MASS SPECTROMETRY. |
| [14] | "Localization, regulation and function of type II phosphatidylinositol 5-phosphate 4-kinases." Clarke J.H., Wang M., Irvine R.F. Adv. Enzyme Regul. 50:12-18(2010) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON FUNCTION. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U14957 mRNA. Translation: AAA64835.2. S78798 mRNA. Translation: AAB35041.1. AL513128, AL157707, AL390318 Genomic DNA. Translation: CAH72211.1. EF445009 Genomic DNA. Translation: ACA06044.1. EF445009 Genomic DNA. Translation: ACA06045.1. AL157707, AL390318, AL513128 Genomic DNA. Translation: CAI39585.1. AL390318, AL157707, AL513128 Genomic DNA. Translation: CAH70526.1. CH471072 Genomic DNA. Translation: EAW86140.1. CH471072 Genomic DNA. Translation: EAW86141.1. BC018034 mRNA. Translation: AAH18034.1. | ||||||||||||
| IPI | IPI00009688. | ||||||||||||
| PIR | A55967. S57217. | ||||||||||||
| RefSeq | NP_005019.2. NM_005028.4. | ||||||||||||
| UniGene | Hs.57079. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P48426. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P48426. 3 interactions. | ||||||||||||
| STRING | 9606.ENSP00000365757. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P48426. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 18266879. | ||||||||||||
2D gel databases | |||||||||||||
| OGP | P48426. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P48426. | ||||||||||||
| PeptideAtlas | P48426. | ||||||||||||
| PRIDE | P48426. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 5305. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000376573; ENSP00000365757; ENSG00000150867. | ||||||||||||
| GeneID | 5305. | ||||||||||||
| KEGG | hsa:5305. | ||||||||||||
| UCSC | uc001irl.4. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5305. | ||||||||||||
| GeneCards | GC10M022823. | ||||||||||||
| HGNC | HGNC:8997. PIP4K2A. | ||||||||||||
| MIM | 603140. gene. | ||||||||||||
| neXtProt | NX_P48426. | ||||||||||||
| PharmGKB | PA162399615. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5253. | ||||||||||||
| HOGENOM | HOG000007832. | ||||||||||||
| HOVERGEN | HBG000072. | ||||||||||||
| InParanoid | P48426. | ||||||||||||
| KO | K00920. | ||||||||||||
| OMA | THPIGTP. | ||||||||||||
| OrthoDB | EOG4SQWX1. | ||||||||||||
| PhylomeDB | P48426. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_111217. Metabolism. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P48426. | ||||||||||||
| Bgee | P48426. | ||||||||||||
| CleanEx | HS_PIP4K2A. | ||||||||||||
| Genevestigator | P48426. | ||||||||||||
| GermOnline | ENSG00000150867. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR023610. PInositol-4-P-5-kinase. IPR002498. PInositol-4-P-5-kinase_core. IPR016034. PInositol-4P-5-kinase_core_sub. [Graphical view] | ||||||||||||
| PANTHER | PTHR23086. PTHR23086. 1 hit. | ||||||||||||
| Pfam | PF01504. PIP5K. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00330. PIPKc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS51455. PIPK. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChEMBL | CHEMBL1795194. | ||||||||||||
| ChiTaRS | PIP4K2A. human. | ||||||||||||
| GenomeRNAi | 5305. | ||||||||||||
| NextBio | 20506. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PI42A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P48426 Secondary accession number(s): B0YJ66 Q5VUX3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
